Roche has parted with $1.4 billion upfront to secure rights to an obesity candidate developed by Zealand Pharma, taking its ...

The list price of Mavenclad is around £2,050 per 10mg tablet, although Merck is providing it to the NHS in England at a ...

Manually producing the TLF involves an interplay of biostatisticians, terminology coders, statistical programmers, and ...

Backed by funding from the Gates Foundation, software company Psyon is running a pilot study of a game that aims to raise ...

MSD has opened the doors of a $1 billion manufacturing facility at its site in Durham, North Carolina, that will be used to ...

One of the key open questions in cell and gene therapy is which will win out: autologous cell therapies, where the patient’s own blood is modified at the bedside, or allogeneic therapies, created with ...

The European Commission has proposed new legislation to safeguard the supply of critical medicines in the EU by boosting manufacturing within the bloc and reducing dependency on suppliers from other ...

The results of the Intuition Brain Health study – sponsored by Biogen and supported by Apple – show the feasibility of using ...

A head-to-head trial of HexaBody-CD38 versus Darzalex Faspro revealed an overall response rate (ORR) of 55% and 52%, ...

Pfizer paid a whopping $1 billion upfront for rights to vepdegestrant (formerly ARV-4710 in 2021 – consisting of $650 million ...

Abzena, a San Diego-based CDMO and CRO focused on bioconjugates and complex biologics, has welcomed Taylor Boyd as its new ...

They are following in the footsteps of NHS chief executive Amanda Pritchard and medical director Sir Stephen Powis, who have ...